growth stocks

The self-confessed market maniac sat down with Livewire to explain its stock picking philosophy and explain Ophir's success.

This business is up more than 20-fold in 5 years, with brokers and fund managers lining up to call it a buy.

Praemium (ASX:PPS) is a growth business trading on 10x forward earnings, with EPS growing >20% for the next 3 years.

While sentiment has changed quickly in just a month, there remains plenty of value in small caps if you look closely.

Rather than worry about losing money on geopolitical risk, some investors are looking at ways to ride it to profit.

This fund could win from a potential rotation out of US stocks into Europe as the continent outperforms and readies an investment boom.

The investment group is backing AI winners and power suppliers as structural growth winners.

Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s mediocre return.

Vihari Ross from Antipodes and James Tsinidis from Munro Partners analyse five global stocks with multi-decade growth opportunities ahead.

Despite sky-high valuations, Jun Bei Liu is bullish on Pro Medicus. She first bought at $25 - now it’s 10x’d. How much higher can it climb?